Report overview
This report contains market size and forecasts of PET Radiopharmaceuticals in global, including the following market information:
Global PET Radiopharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global PET Radiopharmaceuticals Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five PET Radiopharmaceuticals companies in 2021 (%)
The global PET Radiopharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
F-18 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PET Radiopharmaceuticals include Cardinal Health Inc. (U.S.), Mallinckrodt plc (Ireland), GE Healthcare (U.K.), Lantheus Medical Imaging, Inc. (U.S.), Bayer AG (Germany), Bracco Imaging S.p.A (Italy), Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada) and Advanced Accelerator Applications S.A. (France) and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the PET Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PET Radiopharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global PET Radiopharmaceuticals Market Segment Percentages, by Type, 2021 (%)
F-18
Ru-82
Others
Global PET Radiopharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global PET Radiopharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Oncology
Cardiology
Neurology
Others
Global PET Radiopharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global PET Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PET Radiopharmaceuticals revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies PET Radiopharmaceuticals revenues share in global market, 2021 (%)
Key companies PET Radiopharmaceuticals sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies PET Radiopharmaceuticals sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
